[1]
|
[1]MORAN A,GU D,ZHAO D,et al.Future cardiovascular disease in china:Markov model and risk factor scenario projections from the coronary heart disease policy model-China[J].Circ Cardiovasc Qual Outcomes,2010,3(3):243-252.
|
[2]
|
[2]SMITH SC J R,ZHENG Z J.The impending cardiovascular pand-emic in China[J].Circ Cardiovasc Qual Outcomes,2010,3(3):226-227.
|
[3]
|
[3]CHENG S,MASSARO J M,FOX C,et al.Adiposity,cardiometabolic risk,and vitamin D status:the Framingham Heart Study[J].Diabetes,2010,59(1):242-248.
|
[4]中华医学会心血管病分会,中华心血管病杂志编辑委员会,中国循环杂志编辑委员会.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725.
|
[5]
|
[5]BAZAN J F,BACON K B,HARDIMAN G J.A new class of membrane bound chemokine with a CX3C motif[J].Nature,1997,385(9):640-644.
|
[6]
|
[6]HASKELL C A,CLEARY M D,CHARO I F.Unique role of the chemokine domain of fractalkine in cell capture.Kinetics of receptor dissociation correlate with cell adhesion[J].J Biol Chem,2000,275(10):34183-34189.
|
[7]
|
[7]IMAI T,HIESHIMA K,HASKELL C,et al.Identification and molecular characterization of fractalkine receptor CX3CR1,which mediates both leukocyte migration and adhesion[J].Cell,1997,91(4):521-530.
|
[8]
|
[8]WHITE G E,GREAVES D R.Fractalkine:a survivor’s guide:chemokines as antiapoptotic mediators[J].Arterioscler Thromb Vasc Biol,2012,32(3):589-594.
|
[9]
|
[9]WHITE G E,TAN T C,JOHN A E,et al.Fractalkine has anti-apoptotica and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signaling[J].Cardiovasc Res,2010,85(4):825-835.
|
[10]
|
[10]APOSTOLAKIS S,KRAMBOVITIS E,VLATA Z,et al.CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients:impact of pre-inflammatory stimuliand renin-angiotensin system modulators[J].Thromb Res,2007,121(3):387-395.
|
[11]
|
[11]IKEJIMA H,IMANISHI T,TSUJIOKA H,et al.Upregulation of fractalkine and its receptor,CX3CR1,is associated with coronary plaque rupture in patients with unstable angina pectoris[J].Circ J,2010,74(2):337-345.
|
[12]安结,毕磊,郑柳颖,等.趋化因子受体Cx3CRl的基因多态性与冠状动脉粥样硬化的相关性研究[J].大连医科大学学报,2008,30(4):314-317.
|
[13]
|
[13]OTILIA POSTEA,VASINA,SANDRA CAUWENBERGHS,et al.Contribution of platelet CX3CR1 to platelet monocyte complex formation and vascular recruitment during hyperlipidemia[J].Arterioscler Thromb Vasc Biol,2012,32(1):1186-1193.
|
[14]
|
[14]IDA UNHAMMER NJERVE,SVEIN SOLHEIM,KETIL LUNDE,et al.Fractalkine levels are elevated early after PCI-treated ST-elevation myocardial infarction;no influence of autologous bone marrow derived stem cell injection[J].Cytokine,2014,69(9):131-135.
|
[15]齐天军,陈文强,姜翠玲,等.趋化因子促进冠状动脉粥样硬化斑块不稳定的分子机制[J].中华心血管病杂志,2011,39(9):797-801.
|
[16]刘君,雷明明,王妍,等.FKN在急性心肌梗死早期诊断中的作用[J].中国医科大学学报,2015,44(4):307-314.
|
[17]刘军锋,李旭,贾克刚,等.LOX-1和CX3CRl与冠状动脉狭窄性疾病关系及其预后价值的探讨[J].中华检验医学杂志,2014,37(1):66-70.
|
[18]戴青原,李明阳,杨萍,等.冠心病患者血浆纤维蛋白原、血栓前体蛋白水平与冠状动脉病变程度的相关性[J].昆明医科大学学报,2015,36(9):113-117.
|
[19]彭民安,刘传垠,万凤福,等.NT-pro BNP与冠状动脉病变严重程度的相关性[J].昆明医科大学学报,2013,34(8):81-83.
|
[20]于雪,张倩,刘君萌,等.冠心病患者经皮冠脉成形术前后血清亲环素A浓度变化[J].昆明医科大学学报,2015,36(11):31-34.
|
[21]孟丽红,张松.ACS合并混合型高脂血症患者调脂治疗1例报道[J].昆明医科大学学报,2014,35(3):156-157.
|
[22]章丽霞,王宇,张丽华,等.转化生长因子β1和细胞外信号调节激酶1/2在冠心病猝死早期心肌缺血中的表达及意义[J].川北医学院学报,2016,31(6):813-815.
|
[23]梁敏,李阳,张尔永.ACE、ACE2基因在急性主动脉夹层和冠心病患者中表达的差异性研究[J].川北医学院学报,2015,36(4):501-505.
|